(Q41260496)

28 September 2017

title

Comparison of the effects of recombinant interleukin 6 and recombinant interleukin 1 on nonspecific resistance to infection (English)

1 reference

28 September 2017

Van der Meer JW

1

1 reference

28 September 2017

Helle M

series ordinal

2

1 reference

28 September 2017

Aarden L

series ordinal

3

1 reference

28 September 2017

language of work or name

English

0 references

publication date

1 February 1989

1 reference

European Journal of Immunology

28 September 2017

published in

1 reference

28 September 2017

volume

19

1 reference

28 September 2017

issue

2

1 reference

28 September 2017

page(s)

413-416

1 reference

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

28 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190229

A low dose of recombinant interleukin 1 protects granulocytopenic mice from lethal gram-negative infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190229

7 January 2021

Protection of neutropenic mice from lethal Candida albicans infection by recombinant interleukin 1.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190229

7 January 2021

Production of hybridoma growth factor by human monocytes.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190229

7 January 2021

Structural analysis of the sequence coding for an inducible 26-kDa protein in human fibroblasts

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190229

7 January 2021

A growth-factor dependent B-cell hybridoma.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190229

7 January 2021

Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190229

7 January 2021

cDNA cloning of murine interleukin-HP1: homology with human interleukin 6.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190229

7 January 2021

Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190229

7 January 2021

Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190229

7 January 2021

Functional discrimination between interleukin 6 and interleukin 1

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190229

7 January 2021

The effects of recombinant interleukin-1 and recombinant tumor necrosis factor on non-specific resistance to infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190229

7 January 2021

Synergy of interleukin 1 and granulocyte colony-stimulating factor: in vivo stimulation of stem-cell recovery and hematopoietic regeneration following 5-fluorouracil treatment of mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190229

7 January 2021

Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190229

7 January 2021

Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190229

7 January 2021

Interleukin 1 potentiates the lethal effect of tumor necrosis factor alpha/cachectin in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830190229

7 January 2021

Identifiers

DOI

10.1002/EJI.1830190229

1 reference

28 September 2017

1 reference